Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

254 results about "Cellular organisms" patented technology

Cellular organisms means the organisms which are formed of cells. They can be classified on the basis of number organisms That is all prokaryotes, algae etc.Those made of more then one cell is called multicellular. and the division of labour is found in different cells of the organism.For example generally eukaryotes like humans plants etc.

Compounds targeting blood vessels and their medical devices and their application in phototherapy for reducing redness

A compound, as shown in Formula I, is a multi-heterocyclic compound. It has been verified that the compound provided by this invention integrates a novel compound targeting the calcitonin gene-related peptide (CGRP) based on ephedrine. Upon contact with the skin, due to photoactivated cell biological function regulation and the blocking effect of the multi-heterocyclic compound I structure on serotonin receptors, it achieves therapeutic effects on cutaneous vascular malformations and telangiectasia, improves the effectiveness of phototherapy in improving chronic cutaneous vascular diseases, and promotes skin wound healing.
Owner:SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Product, system and method of cell cultivation

The present invention relates to a cell biomass (e.g. food product or pet food product) or its components prepared from cultivated metazoan cells, method of its preparation and a system for its preparation.
Owner:BTL HEALTHCARE TECH AS

Neutralizing antibody GR75 for resisting novel coronavirus SARS-CoV-2 and variant and application of neutralizing antibody GR75

The invention discloses a novel coronavirus neutralizing antibody, a detection kit and application of the novel coronavirus neutralizing antibody. The amino acid sequence of a heavy chain variable region of the neutralizing antibody is shown as SEQ ID No.1, and the amino acid sequence of a light chain variable region of the neutralizing antibody is shown as SEQ ID No.2. The antibody with mature affinity is screened through bioinformatics analysis of a single B cell, the antibody screening process is optimized by combining single cell RNA sequencing, VDJ rearrangement analysis and somatic cell hypermutation research, blindness of a traditional method is avoided, and the accuracy and effectiveness of antibody screening are improved. According to the neutralizing antibody GR75 provided by the invention, a heavy chain variable region and a light chain variable region of the neutralizing antibody GR75 can be specifically combined with an RBD structural domain of the SARS-CoV-2 and an S-Trimer structural domain of an Omicro variant, so that a broad-spectrum neutralizing effect on the SARS-CoV-2 virus and the variant thereof is realized. The binding activity of the antibody GR75 to S-Trimer and RBD under 2-fold and 300-fold dilution conditions is obviously superior to that of other antibodies, which indicates that the antibody GR75 has high affinity and dilution stability and is suitable for clinical large-dose administration.
Owner:BEIJING YOUAN HOSPITAL CAPITAL MEDICAL UNIV +1

Neutralizing antibody GR46 for resisting novel coronavirus SARS-CoV-2 and variant and application of neutralizing antibody GR46

The invention discloses a novel coronavirus neutralizing antibody GR46, a detection kit and application of the novel coronavirus neutralizing antibody GR46. The amino acid sequence of a heavy chain variable region of the neutralizing antibody is shown as SEQ ID No.1, and the amino acid sequence of a light chain variable region of the neutralizing antibody is shown as SEQ ID No.2. The antibody with mature affinity is screened through bioinformatics analysis of a single B cell, the antibody screening process is optimized by combining single cell RNA sequencing, VDJ rearrangement analysis and somatic cell hypermutation research, blindness of a traditional method is avoided, and the accuracy and effectiveness of antibody screening are improved. According to the neutralizing antibody GR46 provided by the invention, a heavy chain variable region and a light chain variable region of the neutralizing antibody GR46 can be specifically combined with an RBD structural domain of the SARS-CoV-2 and an S-Trimer structural domain of an Omicro variant, so that a broad-spectrum neutralizing effect on the SARS-CoV-2 virus and the variant thereof is realized. The binding activity of the antibody GR46 to S-Trimer and RBD under 2-time and 300-time dilution conditions is obviously superior to that of other antibodies, which indicates that the antibody GR46 has high affinity and dilution stability and is suitable for clinical large-dose administration.
Owner:BEIJING YOUAN HOSPITAL CAPITAL MEDICAL UNIV +1

Culture medium and culture method for fish primary liver cells

The invention belongs to the technical field of cell biology, and particularly discloses a culture medium and a culture method of fish primary liver cells. The culture medium of the fish primary liver cells comprises the following components: 90% of an M199 culture medium, 10% of fetal calf serum, 100 U / mL of penicillin, 0.1 mg / mL of streptomycin, 5 ng / mL of EGF, 10 [mu] U / ml of insulin and 10 mM of dexamethasone. Based on the culture medium, an efficient and stable fish liver cell culture method is developed by combining a standardized anesthesia and disinfection process, a precise dissection and liver sampling method, an optimized tissue digestion and cell separation scheme, an efficient cell purification and adherent culture system, a stable passage technology and the like; a standardized hepatocyte line establishment operation process is defined, and the problems that species binding exists in an existing fish liver cell culture method, and a standardized culture process suitable for multiple fish fingerlings is difficult to form are solved.
Owner:NINGBO UNIV

Preparation method and application of recombinant human-like collagen

The invention discloses a preparation method and application of recombinant human-like collagen. The recombinant human-like collagen is fusion protein of collagen and elastin. The preparation method comprises the following steps: taking constructed escherichia coli engineering bacteria, inducing expression of human-like collagen through high-density fermentation, performing high-pressure homogeneous cell disruption after tubular centrifugal collection of fermented thalli, performing acid regulation, flocculating and settling of cell debris and host protein, and controlling pH and conductivity of feed liquid to obtain the human-like collagen. Through ion exchange chromatography purification and ultrafiltration concentration replacement, a human-like collagen stock solution with the liquid phase purity of more than 98% is obtained, and the total yield is more than 75%. Through cell biological activity detection and analysis, the purified human-like collagen has remarkable biological activity of promoting cell migration and adhesion. The whole preparation process developed by the invention is simple and convenient in process, high in yield, easy to amplify and suitable for industrial production of the recombinant human-like collagen, and the prepared protein raw material can be widely applied to the fields of medical beauty and biological medicine.
Owner:赣江中药创新中心

Methods and products for transfecting cells

The present invention relates in part to nucleic acids encoding proteins, nucleic acids containing non-canonical nucleotides, therapeutics comprising nucleic acids, methods, kits, and devices for inducing cells to express proteins, methods, kits, and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods for inducing cells to express proteins and for reprogramming and gene-editing cells using RNA are disclosed. Methods for producing cells from patient samples, cells produced using these methods, and therapeutics comprising cells produced using these methods are also disclosed.
Owner:FACTOR BIOSCIENCE INC

Cell image segmentation and function prediction method and device and computer equipment

The invention discloses a cell image segmentation and function prediction method and device and computer equipment. The method comprises the steps of obtaining a to-be-processed cell image; inputting the to-be-processed cell image into the segmentation model for segmentation to obtain physical morphological features; inputting the physical morphological characteristics into a function prediction model to predict relevant parameters of the cell biological characteristics and relevant indexes of a set type of curative effect so as to obtain the parameters of the cell biological characteristics and the relevant indexes; and outputting physical morphological characteristics, cell biological characteristic parameters and related indexes. By implementing the method provided by the invention, the undyed bright field cell image can be effectively processed, the cell morphology and function are associated, the method is specially used for segmenting the mesenchymal stem cells, and the problem of instance segmentation under the condition of cell overlapping is solved.
Owner:CELLAUTO BIOLOGICAL AUTOMATION CO LTD

Culture medium for inducing neural stem cells and application thereof

PendingCN121343904ANervous system cellsNon-embryonic pluripotent stem cellsEssential aminoacidNeuroectoderm
The invention relates to the technical field of cell biology, in particular to a culture medium for inducing neural stem cells and application thereof.The culture medium for inducing the neural stem cells comprises a neural ectoderm induction culture medium and a neural stem cell induction culture medium; the neural ectoderm induction culture medium is prepared from a basic culture medium, an N-2 additive, a B-27 additive, an inhibitor SB431542 and an inhibitor Dorsomorphin, the neural stem cell induction culture medium is prepared from a basic culture medium, an N-2 additive and a B-27 additive, the basic culture medium is composed of a DMEM / F12 culture medium, a Neurobase culture medium, GlutaMax and non-essential amino acid NEAA. The problems that neural stem cells obtained through an existing single-layer adherent induction method based on small molecules or growth factors are uneven in differentiation and low in purity are solved.
Owner:GUANGZHOU UBIGENE BIOSCIENCES CO LTD

Multi-layer heterogeneous network unicellular organism network inference method based on meta-path enhancement

PendingCN121811981AData visualisationProteomicsHeterogeneous networkGene interaction network
The invention discloses a multi-layer heterogeneous network unicellular organism network inference method based on meta-path enhancement, which mainly comprises a gene regulation knowledge base enhanced multi-layer heterogeneous network construction module for integrating an external gene interaction network and multiple omics data such as scRNA-seq, scATAC-seq, ST and the like; constructing a single-cell multi-omics multilayer heterogeneous network containing cell-cell, cell-gene and gene-gene relationships, and fusing spatial constraints to consider cell positions and tissue structures; and the feature enhancement module based on the meta-path explores complex semantics of the network by designing a multi-hop meta-path mode, designs an adaptive multi-view learning framework and a multi-round enhancement mechanism, and optimizes feature representation by using cell-gene interaction and cross-modal attention fusion. The unicellular biological network can be effectively deduced, the deduction accuracy and biological interpretation are remarkably improved, the method plays an important role in understanding the cell biological process, developing and treating diseases and the like, has good expandability, and can further integrate multi-modal omics data such as proteomics and metabonomics.
Owner:HEBEI UNIV OF TECH

Tissue dissociation liquid, tissue dissociation method and application of tissue dissociation liquid

The invention discloses a tissue dissociation liquid, a tissue dissociation method and application thereof, and relates to the technical field of cell biology. In a DMEM / F12 culture medium, the tissue dissociation liquid only contains the following raw materials in concentration: 0.5 to 3 mg / mL of type II collagenase, 0.5 to 2 mg / mL of type IV collagenase, 0.5 to 2 mg / mL of hyaluronidase, 10 to 18 [mu] M of Y27632 and 80 to 150 [mu] g / mL of primocin. The tissue dissociation liquid provided by the invention can dissociate normal tissues or tumor tissues into single cells or cell clusters, the single cells obtained by the digestion method are high in proliferation rate and easy to successfully culture, and the tissue dissociation liquid has the technical advantages that the cell yield and survival rate are maintained at a relatively high level. Therefore, the tissue dissociation liquid provided by the invention has good application prospects in tumor tissue dissociation, cell line construction and organoid model construction.
Owner:JETLIFE TECHNOLOGY (HANGZHOU) CO LTD

Method for rapidly constructing IgG antibody high-expression stably-transfected CHO cell strain

The invention is applicable to the technical field of biotechnology and cell biology, and provides a method for quickly constructing an IgG antibody high-expression stably-transfected CHO cell strain, which comprises the following steps: S1, constructing antibody plasmids; s2, carrying out cell resuscitation, passage and plasmid transfection; s3, screening positive cells; s4, preparing, namely screening high-expression stably transfected single cell clones; s5, cell feeding batch culture; s6, verifying the stability of the cell strain expressed by the antibody, according to the method provided by the invention, after the plasmid vector enters the cell through electrotransfection and standing culture is carried out for 48 hours, shaking culture is carried out, the cell recovery time can be shortened, the recovery speed is higher than that of traditional standing culture, and the cell state is better than that of a standing state; according to the method, high-density cells are inoculated during cell fed-batch culture, and under the high-density inoculation, the logarithmic phase of the cells is shortened, and the cells enter a protein production phase earlier, so that higher expression quantity can be achieved, the overall production period is greatly shortened, and a large amount of cost is saved.
Owner:ZHEJIANG LONGI BIOTECHNOLOGY CO LTD

Recombinant lentivirus capable of indicating bovine spermatogonial stem cell differentiation, spermatogonial stem cell line and application

The invention provides a recombinant lentivirus capable of indicating bovine spermatogonial stem cell differentiation, a spermatogonial stem cell line and application, and belongs to the technical field of cell biology. The invention provides a method for constructing a spermatogonial stem cell line for indicating bovine sperm differentiation on the basis of a lentivirus transduction technology, and a visual detection system for differentiating spermatogonial stem cells into spermatoblasts is constructed by regulating expression of mCherry protein by utilizing a PRM1 promoter. According to the method, the expression of PRM1 is indicated by fluorescent protein mCherry, so that the differentiation process of the bovine spermatogonial stem cells is indicated, and a good tool is provided for the induction of differentiation of the bovine spermatogonial stem cells to sperms, the research of a development mechanism and the optimization of a differentiation system of the bovine spermatogonial stem cells. The method is a new way for solving the neck clamping problem that good-variety bovine sperms are difficult to obtain in scientific research and production, can also be used for optimization of a spermatogonial stem cell differentiation system, sorting and purification of sperms, even downstream research of drug screening and the like, and has a good application prospect.
Owner:NORTHWEST A & F UNIV

Method for preparing germination-promoting fungal protoplasts directly from orchid protocorms

PendingCN122357291ABiotechnologyMicroorganism
This application belongs to the fields of microbiology and cell biology, and provides a method for directly preparing germination-promoting fungal protoplasts from orchid protocorms, comprising: (1) physical homogenization; (2) filtration; (3) removal of plant contents and residual cell walls; (4) purification of mycelial clusters; and (5) release and purification of fungal protoplasts. Through the rational design of homogenization and purification steps, this application achieves high-yield, high-purity, and high-vitality preparation of germination-promoting fungal protoplasts, providing excellent materials for orchid gene variety breeding and genetic engineering operations.
Owner:INST OF MEDICINAL PLANT DEV CHINESE ACADEMY OF MEDICAL SCI

Compounds for RNA capping and uses thereof

The invention relates to two compounds for RNA capping and application thereof, and belongs to the technical field of genetic engineering. The compound has a structure as shown in a formula (I), can be used as an initial capping oligonucleotide primer, is used for capping an mRNA 5'end, and has good capping efficiency and protein expression quantity; meanwhile, due to the fact that the fluorescent group marker is arranged, the fluorescent group marker can be used for detecting and tracking dynamic changes of mRNA in cells and living bodies, the delivery process, pharmacokinetics and other performance of mRNA in the cells or living bodies can be conveniently researched, and convenience is provided for research of mRNA vaccines / drugs in the cells or living bodies. # imgabs0 #
Owner:GUANGZHOU HENOVCOM BIOSCI CO LTD

A chunky cell culture meat and a method of preparing the same

The present application provides a kind of block cell culture meat and its preparation method.The present application meets the demand of seed cell large-scale preparation of block cell culture meat by suspension cell scale culture, and realizes the adhesion, proliferation and integration of seed cell on edible scaffold material by specific culture medium induction of suspension cell adhering to wall.The method can be in stirred tank cell bioreactor by sterile scaffold material and cooperate with specific induction culture solution and stirring process, so that the adhesion rate of cell and scaffold material reaches 96.8%.The method uses suspension cell as seed cell, and combines corresponding process and culture medium, effectively solves the problems of seed cell difficult to be large-scale prepared and difficult to be effectively integrated with scaffold material in the culture process of block cell culture meat, and provides scalable scheme for industrialized production of block cell culture meat.
Owner:SHAANXI FUTURE MEAT MEAL HEALTH TECH CO LTD

Method for regulating and controlling growth of mammary epithelial cells of milk goats based on KLC1-chi-miR-423-5p-PDGFAceRNA network

The invention discloses a method for regulating and controlling the growth of mammary epithelial cells of milk goats based on a KLC1-chi-miR-423-5p-PDGFAceRNA network, and belongs to the field of animal molecular biology and cell biology. Through combination of transcriptome sequencing and functional verification, it is revealed for the first time that KLC1 can be used as ceRNA, and targeted inhibition of chi-miR-423-5p on PDGFA mRNA is effectively relieved through competitive combination of chi-miR-423-5p, so that proliferation of mammary epithelial cells is promoted, and apoptosis is inhibited. The research results of the invention not only fill the blank of research on the regulation and control mechanism of the breast epithelial cell ceRNA network of the milk goat, but also provide a theoretical basis for breast development regulation and control, tissue repair and prevention and treatment of related diseases, and lay an important foundation for developing a potential molecular intervention strategy.
Owner:TARIM UNIV

High-yield lentivirus cell line and preparation method thereof

The invention discloses a high-yield lentivirus cell line and a preparation method thereof, and belongs to the technical field of molecular biology and cell biology. In order to improve the yield of the lentivirus, the invention provides a recombinant cell which is a cell without a specific gene. The specific genes are any one, two, three, four, five, six or seven of an LDAH protein coding gene, a GBP3 protein coding gene, a BPIFC protein coding gene, an NHLRC1 protein coding gene, a ZNF425 protein coding gene, an NHLRC3 protein coding gene and an SKIC3 protein coding gene. A CBE base editor and a specific gRNA sequence are jointly transfected into an HEK293T cell, the editing efficiency is detected through sequencing, and a stable recombinant cell line for efficiently producing the lentivirus is successfully established and applied to lentivirus production.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI +1

Fibroblast cell activating protein inhibitor-chlorine-containing indole heptamethine cyanine dye coupled near-infrared fluorescent probe, preparation method and medical application thereof

The invention relates to a compound as shown in a formula (I) and / or a formula (II) and / or a formula (III) or a tautomer or pharmaceutically acceptable salt thereof, a preparation method and application of the compound or the tautomer or the pharmaceutically acceptable salt in medicine. Specifically, the fluorescent probe can be used as a fluorescent probe for cytological imaging, can also be used as a near-infrared fluorescent imaging probe for diagnosing benign / malignant lesions such as fibrosis, nodules and tumors, and can also be applied to research of related biological events in cytobiology and molecular biology. The fluorescent probe can be particularly applied to fluorescent navigation in tumor resection surgery.
Owner:SUZHOU YUANJU PHARMACEUTICAL TECHNOLOGY CO LTD

Cell culture medium supplement as well as preparation method and application thereof

The invention discloses a cell culture medium supplement as well as a preparation method and application thereof, and relates to the technical field of cell biology. The supplement comprises DL-alpha-tocopheryl acetate, linolenic acid, ethanolamine, L-carnitine hydrochloride, 3, 3 ', 5-triiodoL-sodium thyrosinate, and serum albumin. As a cell culture additive with definite chemical components and simple composition, the cell culture additive can replace a traditional culture system with unknown chemical components or too complex composition, and is used for supporting proliferation, differentiation and characterization analysis of cells. The culture medium additive is clear in chemical component, simple to prepare, stable in effect and relatively low in cost, can promote in-vitro proliferation and oxidation resistance of cells including human embryonic stem cells and mesenchymal stem cells, and has important application value in actual production.
Owner:UNIV OF MACAU

An anti-aging composition for promoting intercellular communication of skin cells and use thereof

The present application relates to a kind of anti-aging composition for promoting intercellular communication of skin cell and its application, the composition includes the following components: camellia japonica flower extract, bacillus fermentation product, european linden extract and safflower glucoside, the weight ratio of the camellia japonica flower extract, bacillus fermentation product, european linden extract and safflower glucoside is (1-10):(1-8):(1-6):(0.1-1).The anti-aging composition of the present application can promote the activity of skin communication cell, strengthen intercellular communication and interaction, fully exert the function of cell biology, achieve the effect of anti-aging;And inhibit the damage of cortisol to skin barrier, achieve the effect of repair and emotional stress relief, synergistic effect between components, can achieve the best wrinkle, firming, smoothing and repair effect.
Owner:N O D TOPIA (GUANGZHOU) BIOTECHNOLOGY CO LTD

Cell bioreactor and use method thereof

The invention discloses a cell bioreactor and a use method thereof, and relates to the technical field of cell biologication.The cell bioreactor comprises a workbench, a box is fixedly connected to the bottom face of the workbench, a through groove is formed in the middle of the top face of the workbench, and a transverse plate is fixedly connected to the middle of the through groove; a liquid mixing box is arranged on the top face of the workbench, and a box door is arranged on the top of the liquid mixing box. The device further comprises a sliding assembly, limiting assemblies and a driving assembly, the sliding assembly is arranged on the workbench and used in cooperation with the liquid mixing box, the limiting assemblies are arranged on the two sides of the liquid mixing box and used in cooperation with the liquid mixing box, and the driving assembly is arranged on the transverse plate and used for moving the liquid mixing box back and forth. The device is reasonable in structure, the bracket moves back and forth through the driving assembly, and then cells in the liquid mixing box and a culture solution are mixed more uniformly through cooperative use of the sliding assembly and the limiting assembly.
Owner:JI JING JING SHENG (JILIN) BIOTECHNOLOGY CO LTD

Application of neuropeptide Y1 receptor antagonist in preparation of hereditary polycystic kidney disease treatment medicine

PendingCN122005518AOrganic active ingredientsUrinary disorderReceptor subtypeNeuropeptide AF
The invention relates to the technical field of medicines, in particular to application of a neuropeptide Y1 receptor antagonist in preparation of a hereditary polycystic kidney disease treatment medicine. The neuropeptide Y1 receptor antagonist is selected from a compound BIBO3304 which plays a role in blocking combination of neuropeptide Y (NPY) and a Y1 receptor subtype thereof. On the basis that early-stage histopathology, high-throughput sequencing, cytobiology and molecular biology are combined with in-vitro cell culture and in-vivo animal experiments, the potential treatment effect of the neuropeptide Y1 receptor antagonist in preparation of hereditary polycystic kidney disease treatment drugs is provided, and a new basis is provided for hereditary polycystic kidney disease treatment.
Owner:THE NAVAL MEDICAL UNIV OF PLA

A molecular genetic marker affecting sexual maturation in swine and uses thereof

The application discloses a molecular genetic marker affecting pig sexual maturity and application thereof. The application takes RBP1 as a research object, and adopts molecular and cell biology methods to study the correlation between RBP1 and the initial estrus period. It is found that six SNP sites in the RBP1 promoter region are related to the initial estrus period. Further research shows that the promoter activity of the CC genotype of the g.80408109T>C site is significantly higher than that of the TT genotype, the promoter activity of the AA genotype of the g.80409632A>G site is significantly higher than that of the GG genotype, and it is confirmed that RBP1 can inhibit the ferroptosis of granulosa cells. It can be seen that the mutation in the RBP1 promoter region can affect the expression of RBP1, and RBP1 can accelerate the initial estrus start by inhibiting the ferroptosis of pig ovarian granulosa cells. The application has good application value for the research on ovarian follicle development and initial estrus start.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Integrated platform for selective microfluidic particle processing

The instrument for processing microscopic particles may include a combination of modules integrated into a functional system. The system may be composed of synchronized subsystems including pneumatic modules, fluorometers, multi-wavelength lasers, dual view microscopy, high-voltage generators and other subsystems designed to analyze and control microfluidic processes occurring on a chip. The system performs the combined functions of microfluidic particle generation, analysis, and selection, making it possible for the user to create custom integrated workflows for molecular and cell biology processing. Creating the integrated platform requires an innovative and multi-disciplinary approach for module mechanical integration, electronic synchronization and user interface design for controlling diverse microfluidic processes at high speed.
Owner:DROPLET GENOMICS UAB

Polypeptide with lung enrichment capacity as well as derivative and application thereof

The invention discloses a polypeptide with lung enrichment capacity and a derivative and application thereof, and belongs to the field of medical cell biology. And the sequence of the polypeptide with the lung enrichment capacity is PMIDGQKAGRRCVGEQAYCAV. The invention further discloses a preparation method of the polypeptide with the lung enrichment capacity. The polypeptide molecule has specific recognition capability on lung, can recognize and target lung tissues, and provides a unique recognition tool for diagnosis and treatment of lung-related diseases. Due to the specificity of the sequence, the polypeptide can be applied to a drug delivery tool of a lung disease animal model, and has potential clinical application value.
Owner:SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI

Biosensor for sensing tylosin, construction method of biosensor and MphR mutant protein based on biosensor

The invention discloses a tylosin sensing biosensor, a construction method thereof and MphR mutant protein based on the tylosin sensing biosensor, and belongs to the technical field of gene engineering. The technical problem to be solved by the invention is how to detect tylosin. In order to solve the technical problem, the invention provides the biosensor for sensing tylosin, the biosensor can express an MphR31D1 protein and / or a coding gene containing the MphR31D1 protein, and the MphR31D1 protein can be a protein with an amino acid sequence of SEQ ID NO: 1. The invention also provides a preparation method of the biosensor, and application of the MphR31D1 protein and related biological materials thereof in detection of tylosin. According to the invention, escherichia coli Top10 is taken as a chassis bacterium, a macrolide compound transcriptional regulation factor MphR is taken as a starting template, and the tylosin whole-cell biosensor is successfully constructed through protein directed evolution.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI +1

Adjustable animal tissue slicing device

The utility model relates to the technical field of animal tissue slicing, and discloses an adjustable animal tissue slicing device which comprises a main body shell, a driving module is arranged on the side wall of the main body shell, a conveying piece is fixedly connected to the inner side wall of the main body shell, and a transverse groove is formed in the conveying piece. On the premise of an automatic cutting mechanism, the slicing precision and uniformity can be improved, and the problem of non-uniform slicing thickness caused by human factors such as hand shaking and non-uniform force application in manual operation is effectively avoided; the thickness of each time of cutting can be accurately controlled, the consistency of the thickness of the slices is ensured, and a highly reliable and repeatable data basis is provided for subsequent histological analysis, pathological diagnosis and cell biology research, so that the accuracy and reliability of experimental results are improved, experimental errors caused by the thickness difference of the slices are reduced, and the experimental efficiency is improved. And scientific researchers can more accurately reveal the microstructure and pathological change characteristics of tissue cells.
Owner:SHANDONG AGRICULTURAL UNIVERSITY

Apis cerana heat resistance related gene Hsc70-4 and application of encoding protein thereof

The invention discloses an application of a heat-resistant related gene Hsc70-4 of apis cerana and an encoding protein of the heat-resistant related gene Hsc70-4, and belongs to the technical field of cytobiology and molecular biology. The invention verifies that silent Hsc70-4 can reduce the survival rate of Chinese bees under heat stress, and overexpressed Hsc70-4 can increase the survival rate of drosophila S2 cells under heat stress. Induced expression of Hsc70-4 is helpful for reducing oxidative damage of heat stress to apis cerana and improving heat resistance of apis cerana. In view of the heat resistance of the Hsc70-4, overexpression of the Hsc70-4 in bees or economic animals is expected to be realized through a transgenic technology in the future, so that the heat resistance of the Hsc70-4 is improved, the yield of the Hsc70-4 under a heat stress condition is further improved, and a new gene target is provided for coping with ecological and agricultural challenges under a global warming background.
Owner:QUFU NORMAL UNIV

Multi-parameter flow cytometry detection method and system for ferroptosis phenotype quantification

The invention provides a multi-parameter flow cytometry detection method and system for ferroptosis phenotype quantification, and relates to the technical field of cell biological detection and analysis. By setting a ferroptosis induction control group, a ferroptosis inhibition control group and a group to be detected, lipid peroxidation signals, free iron signals and membrane integrity signals are synchronously collected in the same detection process, and original multi-parameter data are obtained. And performing spectrum unmixing and batch correction by utilizing artificial intelligence, and screening a target event set based on a preset event quality control condition. On the basis, the ferroptosis probability of the event to be detected is calculated, the ferroptosis phenotype index is determined, standardization and quantification of ferroptosis phenotypes are achieved, and the method is suitable for high-throughput screening and clinical evaluation.
Owner:EIGHTH AFFILIATED HOSPITAL SUN YAT SEN UNIV (SHENZHEN FUTIAN)